Form 483

Hawaii Health Systems Corporation dba Kona Community Hospital Pharmacy Form 483, 2019-12-13

FDA issued a Form 483 to Hawaii Health Systems Corporation dba Kona Community Hospital Pharmacy on 2019-12-13 with 8 public-safe observations.

483· Form 483 issuedHuman Drugs8 observations

Hawaii Health Systems Corporation dba Kona Community Hospital Pharmacy · Kealakekua, United States · Issued December 13, 2019

Overview

  • 8 public-safe observations are available for this inspection.
  • 1 structured CFR citation is represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

13 Dec 2019
FDCA 501(a)(2)(A)

Actionable microbial contamination, adjacent area

Cited by Christopher R Czajka, Marcus F Yambot

13 Dec 2019
FDCA 501(a)(2)(A)

Actionable microbial contamination, ISO 5 area

Cited by Christopher R Czajka, Marcus F Yambot

13 Dec 2019
FDCA 501(a)(2)(A)

Air flow quality, higher classified area

Cited by Christopher R Czajka, Marcus F Yambot

13 Dec 2019
FDCA 501(a)(2)(A)

Disinfecting and cleaning agents, ISO 5 area

Cited by Christopher R Czajka, Marcus F Yambot

13 Dec 2019
FDCA 501(a)(2)(A)

Dust-collecting overhangs, surrounding area of ISO 5

Cited by Christopher R Czajka, Marcus F Yambot

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
FDCA 501(a)(2)(A)Cited across public-safe Form 483 observations8x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 8 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere